Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to see the affects of the study medication called mixed
amphetamine salts-extended release (MAS-XR) on brain function by taking brain pictures. The
researchers also want to see if MAS-XR makes your child more or less likely to develop
problems like acting out (i.e. periods of irritability, agitation, aggression).
MAS-XR is approved by the United States Food and Drug Administration (FDA) to treat attention
deficit hyperactivity disorder (ADHD) in adults, children and adolescents.